[VRTX] QoQ Quarter Result on 30-Sep-2013 [#Q3]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
07-Nov-2013
Financial Year
2013
Quarter
30-Sep-2013 [#Q3]
Profit Trend
QoQ- -117.13%
YoY- -115.71%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Revenue 138,421 118,451 351,157 221,700 310,750 328,368 333,994 -44.50%
PBT -158,689 -231,654 -340,253 -129,406 -63,511 -442,940 -80,772 57.05%
Tax 693 803 -155,704 -751 -1,799 -130,313 -2,696 -
NP -159,382 -232,457 44,285 -124,125 -57,165 -308,016 -76,148 63.84%
Tax Rate - - - - - - - -
Total Cost 297,803 350,908 306,872 345,825 367,915 636,384 410,142 -19.26%
Ratio Analysis
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
NP Margin -115.14 -196.25 12.61 -55.99 -18.40 -93.80 -22.80 195.22%
Per Share
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
EPS -0.68 -1.00 0.19 -0.54 -0.26 -1.43 -0.35 55.89%
EPS Diluted -0.68 -1.00 0.19 -0.54 -0.26 -1.43 -0.35 55.89%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.